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Single-cell genome analyses of human oocytes are
important for meiosis research and preimplantation
genomic screening. However, the nonuniformity of
single-cell whole-genome amplification hindered
its use. Here, we demonstrate genome analyses
of single human oocytes using multiple annealing
and looping-based amplification cycle (MALBAC)-
based sequencing technology. By sequencing the
triads of the first and second polar bodies (PB1
and PB2) and the oocyte pronuclei from same fe-
male egg donors, we phase the genomes of these
donors with detected SNPs and determine the
crossover maps of their oocytes. Our data exhibit
an expected crossover interference and indicate a
weak chromatid interference. Further, the genome
of the oocyte pronucleus, including information
regarding aneuploidy and SNPs in disease-associ-
ated alleles, can be accurately deduced from the
genomes of PB1 and PB2. The MALBAC-based
preimplantation genomic screening in in vitro fertil-
ization (IVF) enables accurate and cost-effective
selection of normal fertilized eggs for embryo
transfer.INTRODUCTION
Successful human sexual reproduction starts with meiosis of
an oocyte, which, upon fusion with a sperm cell, results in a fertil-
ized egg whose viability is crucial to producing a healthy
neonate. At the onset, every human oocyte undergoes homolo-
gous recombination of paternal and maternal genomes, which
generates crossovers in individual chromosomes, contributing
to genetic diversity in human evolution. Hence, each human
germ cell has a unique genome, necessitating single-cell1492 Cell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc.sequencing analyses, which have been recently achieved in
sperm (Wang et al., 2012; Lu et al., 2012).
A normal male’s sperm cell has 3%–4% probability of aneu-
ploidy (Hunt and Hassold, 2002), chromosome abnormality
due to their segregation errors, and this percentage may not
change much with age (Fonseka and Griffin, 2011). Sperm cells
with such aneuploidy would result in miscarriage or genetic
disorders (Ferguson et al., 2007). However, aneuploidy occurs
with much higher probability for the female counterpart, an
oocyte, and increases drastically with the age of the female,
which is one of the major causes of the decreasing live birth
rate over time (Qiao et al., 2013).
Primary oocytes (four sets of chromatids, 4C) finish homo-
logous recombination during a female’s fetal period and enter
a more than 10 year arrest at meiosis I. After puberty, in every
menstrual cycle, one of the primary oocytes undergoes cell
division, extrudes a diploid first polar body (PB1), and becomes
a secondary oocyte arresting at meiosis II (Figure 1A). Upon its
fertilization with a sperm cell, the secondary oocyte extrudes a
haploid second polar body (PB2), and the remaining fertilized
egg contains a haploid female pronucleus (FPN), as well as a
haploid male pronucleus (MPN) (Figure 1B).
It is reported that crossovers in human oocytes have a fre-
quency 1.73 higher than that of sperm (Broman et al., 1998).
However, the majority of previous human oocyte crossover
studies have relied on genetic linkage analyses based on family
pedigree, which could be under the influence of selection.
Although cytological assays of homologous recombination in
the human oocytes have allowed analysis of the crossover num-
ber and distribution at the single-cell level, the resolution was
relatively low (Cheng et al., 2009). Using single-cell whole-
genome sequencing analyses, we have carried out the first
detailed study of recombination at high resolution on human
oocyte meiosis, free from the above complications.
Crossover interference along the genome has been implicated
by the nonrandomly distributed crossovers (Fung et al., 2004;
Jeffreys et al., 1998). Sequencing a large number of sperm cells
from a person has enabled identification of individual specific
recombination distribution in males (Lu et al., 2012; Wang
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Figure 1. Schematic Charts of Human
Oocyte Meiosis and Single-Oocyte
MALBAC Sequencing
(A) Illustration of homologous recombination and
chromosome segregation during meiosis process
of human oocytes. Only one chromosome is
shown with red and green colors, indicating the
maternal haplotype and paternal haplotype,
respectively.
(B) Flowchart of experiment procedures. The first
and second polar bodies, dispensable for embryo
development, were safely biopsied by a micropi-
pette, followed by single-cell lysis, MALBAC
amplification, and high-throughput sequencing.
See also Figure S1.et al., 2012), but the counterpart sequencing analysis for oocyte
crossover interference has not been carried out yet. Another type
of genetic interference is chromatid interference, which refers to
the phenomenon that the selection of a nonsister chromatid pair
for a crossover is not random but rather is affected by whether
the chromatids are involved in a neighboring crossover. WeCell 155, 1492–1506, Dehave resolved these issues by simulta-
neously sequencing the triad of the first
and second polar bodies and the female
pronucleus.
This year marked the 35th anniversary
of the birth of the first in vitro fertilization
(IVF) baby, and IVF has resulted in more
than six million test tube babies around
the world. With the increased number of
infertile couples, it is highly desirable to
carry out single-cell sequencing analyses
on individual oocytes or embryos. The
PB1 and PB2, dispensable for human
embryonic development, can be safely
removed with a micropipette, which
has been practiced for preimplantation
genetic diagnosis or screening (PGD
or PGS) in IVF with the goal of selecting
a normal fertilized egg. To date, most of
the methods for PGD/PGS, including
fluorescence in situ hybridization (FISH),
SNP array, and array comparative
genomic hybridization (CGH) (Van den
Veyver et al., 2009), cannot simulta-
neously detect aneuploidy and single-
nucleotide variant (SNVs) associated
with Mendelian diseases of severe defect
phenotypes (Treff et al., 2013; Liss et al.,
2011).
Here, we report the single-cell genomic
studies on donated human oocytes,
which were not transferred into any
of the participants. Single-cell whole-
genome amplification has offered high
genome coverage with much reduced
sequence-dependent bias. With thehigh coverage of MALBAC, we show that the genome of the
FPN, information regarding aneuploidy, and SNVs in disease-
associated alleles in particular can be accurately deduced
from the genomes of PB1 and PB2 if the genetic disorders are
from the mother. If the genetic disorders are from the father,
one can sequence one or a few cells from the blastocyst stagecember 19, 2013 ª2013 Elsevier Inc. 1493
of the embryo. We demonstrate that whole-genome analyses of
single human oocytes based on MALBAC allow accurate and
cost-effective embryo selection for in vitro fertilization.
RESULTS
Single-Cell Whole-Genome Amplification and
Sequencing of Polar Bodies and Female Pronuclei
We recruited eight healthy voluntary Asian female donors, who
are 25–35 years old and have one or two healthy children from
natural pregnancy, with their signed informed consent docu-
ments. The oocytes were collected using standard clinical proto-
cols and then fertilized by intracytoplasmic sperm injection
(ICSI). In total, we obtained 70 fertilized oocytes, on average
8.8 oocytes (4–15) per donor (Figure 2A).
The first and second polar bodies, as well as the female pro-
nuclei of egg cells, were isolated with laser-assisted micro-
manipulation (Figure S1 available online). PB1 and PB2 were
successfully biopsied from 67 (95.7%) and 64 (91.4%) oocytes,
respectively. For verification purpose, the FPN of 52 (74.3%)
oocytes have been biopsied. In total, 183 single cells were
successfully isolated. The genome of each single cell was ampli-
fied by MALBAC and was sequenced at 0.73 depth on HiSeq
2000 (Figure 1B), obtaining genome coverage of 32% for
each single cell on average (Figure S2A and Table S1).
SNP Calling and Phasing of the Donor’s Genome
We determined the heterozygous SNPs (hetSNPs) for a donor
using the single-cell sequencing data of all her donated oocytes
instead of sequencing the donor’s blood DNA. In this study,
combining sequencing data of all oocytes available from the
same individual, for whom the overall sequencing depth varied
from 43 to 373, allows us to achieve individual genome
coverage of 70% to 97% (Figure 2A).
Using an algorithm similar to that of population SNP calling
(Bansal et al., 2010) and following a set of stringent filtering
measurements, we determined 330,000–1,386,000 hetSNPs
for each donor, approximately in proportion with the overall
sequencing depth. Employing the donor’s hetSNP information,
we determined the alleles carried by each single cell at these
SNP loci (Lu et al., 2012). On average, 180,000–670,000 high-
confidence SNPs were determined for a single cell of each
donor, which generally accounts for half of the donor’s total
hetSNPs.
To determine the haplotype from a donor’s hetSNPs, we
primarily exploited the haploid PB2 cells of the oocytes. Two
independent algorithms were implemented, and the results
from themwere comparable, thus verifying the phasing accuracy
(Figures 2B and S2B) (Kirkness et al., 2013; Lu et al., 2012). We
confidently phased the haplotype on 91%–95% hetSNP loci for
each donor at the whole-chromosome level. Then, crossovers
on each chromosome of every individual cell were successfully
inferred with the phased haplotype using a hiddenMarkovmodel
(HMM) (Figures 2C, S2C, and S2D).
Female Personal Genetic Map Construction
For all donors, we identified 2,370 and 2,355 crossovers in PB2
and FPN of 55 euploid oocytes, respectively (Table S1). The1494 Cell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc.average of 43 crossovers per haploid cell is 1.653 of that in
sperm. This phenomenon has been shown previously in mice
that oocytes have a frequency 1.33 higher than that of sperm
(Petkov et al., 2007).
These sex-specific differences likely result entirely from differ-
ences in longitudinal chromosome organization (Kleckner et al.,
2003). At leptotene, chromosomes develop into a synaptonemal
complex (SC), an array of chromatin loops whose bases, elabo-
rated by proteins, comprise a longitudinal structural axis. The
number of loops per micrometer of SC is relatively fixed for
different sexes, regardless of the loop size. Females exhibit longer
SCs than males (Tease and Hulte´n, 2004). Thus, female chromo-
somes will be organized into more loops of smaller average size
(Kleckner, 2006; Novak et al., 2008). Further, recombination initi-
ation complexes develop in association with loop bases (Panizza
et al., 2011). Thus, females will have more initiation complexes
and more initiating double-strand breaks (DSBs). Such propor-
tionality of DSB number to chromosome length has been demon-
strated in C. elegans (Mets and Meyer, 2009). DSBs develop into
interhomolog interactions which, in turn, are operated upon by
crossover interference. The number of crossovers is proportional
to both the number of DSBs and to physical chromosome length.
Proportionality of COnumber andSC length has long been known
formale and female in humanand in other species (Kleckner et al.,
2003; Tease and Hulte´n, 2004).
A moderate correlation (R = 0.61) was observed between the
crossover numbers in the PB2 and FPN from the same oocyte
(Figure 3B). Overall, crossovers do not show significant prefer-
ence for FPN over PB2 in meiosis (paired Student’s t test p value
0.80 and F test p value 0.79), indicating that there is no significant
relationship between the haploid cell fate in meiosis II and the
crossover numbers in its genome.
By binning the crossovers into 5 Mb units in the genome, we
constructed the first set of female personal genetic maps, which
are largely consistent with the sex-averaged map based on
population analysis (HapMap) (Myers et al., 2005) and a
female-specific map based on pedigree analysis (deCODE)
(Kong et al., 2010) on the megabase scale (Figure 3C). Notably,
chromosome X-X recombination of an individual can be
analyzed by sequencing for the first time, which gave a personal
chromosome X recombination rate ranging from 1.01 to 1.18
centimorgan (cM) per Mb, which is similar to the recombination
pattern of autosomes (Tables S2 and S3). However, limited by
the small number of oocytes for each donor, it is not feasible
to detect personal recombination hot spots with statistical sig-
nificance. By merging eight donors’ personal genetic maps, we
obtained a population genetic map that is comparable to
deCODE map (Figure S3A and Table S4).
The improved amplification evenness of MALBAC allowed us
to achieve high resolution in detecting crossovers with low
sequencing depth (Figure 3D). About 95%, 84%, and 55% of
the crossovers could be confidently assigned to intervals of
200, 100, and 30 kb, respectively. With this high resolution, we
were able to study the crossover distributions at a finer genome
scale. We observed a drop of recombination rates in oocyte data
close to the transcription start site (TSS) (Figure 3E), reinforcing
the speculation that the variation of recombination probability
during oocyte meiosis, rather than selection, gives rise to the
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Figure 2. Calling of Heterozygous SNPs, Phasing of the Donor’s Genome, and Detecting of Crossovers
(A) Summary of sequencing information for all of the single cells fromeight donors. The sequencing depth and genome coverage for each cell are shown, aswell as
the summedvalues for eachdonor and the numbersof phased heterozygousSNPs for eachdonor, togetherwith the averagenumbers of phasedSNPs in eachcell.
(B) Schematic chart of phasing the donor’s heterozygous SNPs with several PB2. The genotyped SNPs for each PB2 are lined up, and the consensus SNPs are
inferred for both haplotypes. Note that a rare crossover event occurs in the fifth PB2.
(C) Crossover distribution map of the 23 chromosomes from a second polar body S0110B. The normalized coverage depth that reflects chromosome copy
number is shown on the right side.
See also Figure S2 and Table S1.
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reduced recombination rate close to TSS (Coop et al., 2008). Of
the crossovers unambiguously resolvable within a 10 kb interval,
44% of these crossover intervals overlapped with at least one
PRDM9 binding motif (CCnCCnTnnCCnC), which is consistent
with the recently published study on single sperm cells (Lu
et al., 2012) and previous population studies (Myers et al., 2008).
Crossover Interference in Human Oocytes Compared
with Sperm
Crossover interference is a phenomenon that a chromosomal
crossover at one position decreases the probability for
another crossover occurring nearby. Crossover interference in
human sperm has been recently observed by single-sperm cell
sequencing (Lu et al., 2012; Wang et al., 2012). Here, we report
our study of crossover interference in single human oocytes.
We used coefficient of coincidence (CoC) to describe the
strength of interference. This approach considers the magnitude
of crossover interference as a function of the distance between
crossovers along a chromosome. It provides a chromosome-
wide view, irrespective of nonuniform recombination rate along
the genome (Petkov et al., 2007). Figure 3F shows the CoC for
the crossover interference of oocyte as a function of genetic
distance (number of base pairs), as compared with that for
human sperm (Lu et al., 2012). It is evident that interference
acts over a smaller number of base pairs in oocytes than in
sperm, which is consistent with the fact that oocytes have
more crossovers per chromosome. Furthermore, the CoC curve
of the neighboring crossovers on the same arms of chromo-
somes shows no significant difference from that of all cross-
overs, verifying that the crossovers across centromeres do not
affect the CoC values calculated (Figure S3B).
Further analysis reveals, however, that when we plot the CoC
as a function of the physical distance of the SC length (which is
longer in oocytes than in sperm), the sperm and oocyte’s curves
overlap (Figure S3C). Analogous results have also been found in
mouse (Petkov et al., 2007) and Arabidopsis (Drouaud et al.,
2007). Crossover interference involves the spreading of an inhib-
itory signal along well-organized chromosomes. The fact that
CoC curves for oocyte and sperm overlap when SC length is
used as a metric has two mechanistic implications. First, the
metric for the spreading interference signal is physical distance
along the chromosome, not genomic distance in DNA/base pair
length. Second, the strength of interference, i.e., the distanceFigure 3. Distribution Characteristics of Crossovers in Human Oocyte
(A) Distribution of crossover numbers for single haploid cells (PB2, FPN) and the
(B) Moderate correlation of crossover numbers in the PB2 and FPN from the sam
(C) The personal genetic map of a female individual (donor S01) at 5 Mb resolutio
recombination rate is denoted with cM/Mb (centimorgans per megabase pair).
(D) Distribution of crossover determination resolution at average sequencing d
red curve.
(E) Decrease of recombination rate near TSS. cM, centimorgans.
(F) Crossover interference shows a big difference between two sexes on the gen
(G) Crossover interference study with oocyte triad. The distribution of neighboring
FPN) is shown for comparison.
(H) Weak negative chromatid interference within the same chromosome arm. The
crossover, considering a neighboring crossover on the same chromosome arm. T
pairs nearest to the centromere in the 55 euploid oocytes. The ratio of the three ca
negative chromatid interference.
See also Figure S3 and Tables S2, S3, and S4.
Cover which the inhibitory signal acts along the chromosomes,
is exactly the same in human oocytes and spermatocytes.
Crossover interference happens between neighboring cross-
overs in the four sets of chromatids within the oocyte, whereas
a haploid PB2 or FPN only has half of the total number of
crossovers in the oocyte. We counted the crossovers of PB1,
PB2, and FPN derived from the same oocyte and found that
each oocyte has an average of 76 crossovers (88% of the theo-
retical value 43 3 2) (Table S2), and the distribution of the
distance between two adjacent crossovers is shown in blue in
Figure 3G. These triad data in oocytes capture more crossovers
than the data from PB2 and FPN alone with only an average of 43
crossovers, providing better statistics for human oocyte cross-
over interference, yielding a shorter distance between two adja-
cent crossovers.
Weak Chromatid Interference in Human Oocytes
Another type of genetic interference, chromatid interference,
refers to the phenomenon that the selection of a nonsister chro-
matid pair in one crossover influences the chromatid selection
for a neighboring crossover (Zhao et al., 1995). Unlike the cross-
over interference, chromatid interference has been less studied,
and the reported results are inconsistent (Chen et al., 2008;
Speed et al., 1992; Teuscher et al., 2000). With the meiosis triad
data here, we were able to study chromatid interference by
identifying which nonsister chromatid pair is involved in each
crossover. Considering the anchoring effect of centromeres,
the crossover pairs were counted on the same or different chro-
mosome arms separately.
On the same arm of a chromosome, the two crossovers
nearest to the centromere exhibit four different categories de-
noted as two chromatids, three chromatids (I), three chromatids
(II), and four chromatids (Figure 3H). In our experiment, three out
of the four categories can be distinguished and counted,
whereas one category, three chromatids (I), cannot be identified
because crossovers between the two chromatids are not recog-
nizable in the diploid PB1. The theoretical ratio of the three iden-
tifiable categories should be 1:1:1 in the absence of chromatid
interference. As shown in Figure 3H, a total count of 440
(35%± 1%), 440 (35%± 1%), and 374 (30%± 1%)was observed
for the two chromatids, three chromatids (II), and four chroma-
tids categories, respectively, indicating that there is a weak
and negative chromatid interference in human meiosiss
oocyte triads.
e oocyte (R = 0.61).
n, which is largely consistent with that of HapMap and deCODE (female). The
epth of 0.74. Accumulative percentage of crossover numbers is shown as
omic distance scale.
crossover distances from oocyte triads and the haploid gamete cells (PB2 and
re are four possible recombination categories for chromatid pair selection in a
he numbers for each recombination category are counted from the crossover
tegories is 35 (± 1%): 35 (± 1%): 30 (± 1%), not 1:1:1, suggesting that there is a
ell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc. 1497
(chi-square test, p value 0.03). The positive interference means
that having the first crossover between a pair of chromatids de-
creases the probability of having another crossover between the
second pair containing one of the two original chromatids. The
negative interference means the reverse. The slight but negative
interference is confirmed by our bootstrapping analysis (Fig-
ure S3D), which yields the error bars. We note that weak chro-
matid interference was reported for fungus N. crassa, whereas
no chromatid interference was reported for yeast (Mancera
et al., 2008; Zhao et al., 1995).We are aware of the complications
that differences might exist among chromosomes and various
genome regions. The weak chromatid interference in human oo-
cytes seen in our experiment calls for further investigations on
the underlying mechanism.
In contrast, for crossover pairs on different chromosome
arms, only two observable patterns can be identified (Fig-
ure S3E). One pattern contains the two chromatids and three
chromatids (I) category, whereas the other pattern contains
the four chromatids and three chromatids (II) category. We
observed an almost equal count, 478 (50%) and 477 (50%),
for the two observable patterns, respectively (chi-square test,
p value 0.97), the bootstrapping of which was shown in Fig-
ure S3F. These results suggest that chromatid interference
does not exist when the two crossovers are on the opposite
sides of a centromere.
Allele Deduction of a Female Pronucleus by Sequencing
the First and Second Polar Bodies
It is highly desirable to determine which sets of alleles are
present in an FPN due to homologous recombination without
destroying the FPN. In principle, with the knowledge of the do-
nor’s haplotypes, the FPN alleles can be easily deduced from
those of PB1 and PB2. This deduction is based on the fact that
there should be a total of two copies of both paternal and
maternal DNA when summing up the PB1, PB2, and FPN from
the same oocyte (Figures 4A and 4B). Based on this principle,
we can deduce the alleles of an FPN by sequencing its two
corresponding polar bodies, which facilitates genome-wide
screening of maternal disease-associated alleles in the FPN.
To demonstrate the proof of principle, we sequenced FPNs
under the donors’ consents and compared it with the deductions
from the two corresponding polar bodies. Indeed, 91% of the
predicted haplotypes for FPN, 40 out of 44, were confirmed by
direct sequencing of the FPNs (Figures 4C and S4). Among the
unmatched four oocytes, three have severe DNA degradation
in PB1, and one has intrinsic chromosome abnormality (dis-
cussed below). When the haplotype of an FPN is determined,
all the phased SNPs of the donor are allocated to FPN (Fig-
ure 4B). In so doing, the density of predicted alleles for the
FPN depends solely on the donor’s phased hetSNPs, which
can be further improved by other SNP discovering and phasing
techniques (Wang et al., 1998), enabling high-accuracy and
high-density SNP prediction without destroying the FPN.
Identification of Maternal Mendelian Diseases by
MALBAC-Based Genome-wide PGS
About 7,000monogenic disorders have been estimated (Boycott
et al., 2013), which in total occur in about 1 out of every 2001498 Cell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc.neonates. Usually, every individual carries some heterozygous
disease-associated alleles (Abecasis et al., 2012). If this allele
is dominant, it is desirable to avoid transmission of this maternal
allele to the neonate. If the disease-associated allele is reces-
sive, it is also desirable to avoid transmission of this maternal
allele to the neonate in case the father also carries and contrib-
utes the disease allele to the baby.
PGD for Mendelian diseases can greatly reduce genetic de-
fects (Sermon et al., 2004). The most widely adopted method
for detecting known disease-associated alleles is blastomere bi-
opsy coupled with single-locus PCR (Van de Velde et al., 2000).
However, PCR-based PGD can detect only limited numbers of
suspected loci due to its low throughput. With the predicted
SNPs, we can thoroughly screen undesirable alleles in FPN,
which were associated with severe hereditary genetic diseases.
Among the eight donors’ heterozygous SNV alleles, we found
several potential disease-associated alleles for each donor
(Table S5) using the Human Gene Mutation Database (HGMD).
Taking donor S08 as an example, we identified three potential
disease-associated alleles in genes AGL, GP9, and HPD
(Table 1).
Although these diseases are not severe, they provide hypo-
thetical test cases for the ability to call SNVs for embryo selec-
tion. In principle, the oocytes containing fewer Mendelian
disease-associated alleles can be selected for embryo transfer.
We confirmed the predicted alleles by Sanger sequencing of
the MALBAC product of the 11 female pronuclei under the
donor’s consent (Table 1 and Figure S5). For 32 out of 33 loci,
Sanger sequencing results were consistent with the predictions,
except the one not successfully amplified byMALBAC, andwere
not able to be analyzed by Sanger sequencing. Overall, this
result confirmed the feasibility of detecting and avoiding
genome-wide maternal Mendelian disease-associated alleles
in fertilized eggs.
Detection of Aneuploidy in Oocytes with High Accuracy
and Resolution
Aneuploidy, abnormality of chromosome numbers due to chro-
mosome segregation errors during meiosis, results in miscar-
riage or genetic disorders of neonates. In PGS, CGH and SNP
arrays have been used for aneuploidy screening (Harper and
Sengupta, 2012) but with limited resolution. With MALBAC’s
significantly improved coverage uniformity over other existing
whole-genome amplification methods (Zong et al., 2012), the
aneuploidy can be confidently determined with the raw coverage
depth for an individual oocyte (Figure 5A). Moreover, we found
that MALBAC’s systematical coverage bias on a finer scale is
reproducible genome wide and can be normalized in order to
further reduce the bias (Figures S6A and S6B). Using the normal-
ized coverage depth, the copy number can be accurately deter-
mined at a megabase resolution (Figure 5A).
In order to measure the signal stability, the SD of normalized
coverage depth for each cell was calculated. Most (97%) of
the cells showed only slight bias of coverage depth (SD < 0.36)
except for six (3%) cells (SD > 0.36), including three PB1, one
PB2, and two FPN (Figure 5B). It is difficult to infer the copy
number from coverage depth for these six cells, which may be
due to DNA degradation, inefficient cell lysis, or MALBAC
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Figure 4. Deduction of the Haplotype of FPN by Sequencing the Genomes of PB1 and PB2
(A) Principle of haplotype deduction for the FPN. For a DNA fragment where no crossover occurs, if PB1 is heterozygous, the haplotype of FPN should be different
from that of PB2. Otherwise, the haplotype of FPN should be the same as that of PB2.
(B) Deduction of chromosome haplotype and allocation of genotypes. PB1 and PB2 are separately genotyped, from which the haplotype of FPN is deduced.
However, the SNP density of predicted FPN depends on the phased hetSNPs of the donor.
(C) The predicted haplotype of FPN is clearly confirmed by the sequencing results. The haplotypes of PB1, PB2, predicted FPN (left), and sequenced FPN (right)
are shown for all the chromosomes from oocyte S0110.
See also Figure S4.
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Table 1. Deduction of Mendelian Disease-Associated SNVs in Female Pronuclei of Donor S08
Oocyte ID Gene Name
AGL (C/T) GP9 (G/A) HPD (C/T)
PB1 PB2 FPN (P) FPN (C) PB1 PB2 FPN (P) FPN (C) PB1 PB2 FPN (P) FPN (C)
S0801 N/N N T T N/N N G G T/N C C C
S0802 N/N N C C N/N N G G N/N T T T
S0803 N/N N T T N/N N G G N/N C C C
S0806 N/N C C C N/N N A A N/N N C C
S0807 N/N N C C N/N N A A N/N N C C
S0808 C/N T C C N/N N A A N/N N C C
S0809 C/C N T T N/N N G G N/N T C C
S0811 N/N T T T N/N N A A N/N N C C
S0812 C/C T T T N/N N G D C/T N T T
S0813 N/N C T T N/N N G G N/N T C C
S0815 N/N N C C N/N N A A N/N N T T
For this donor, the corresponding genotypes for 11 FPNs of the oocytes, which have all the PB1, PB2, and FPN recovered and sequenced, are
predicted by the haplotype deduction. The ‘‘N’’ represents the alleles that are not covered by single-cell low-depth sequencing. The underlined bases
represent SNVs associated with Mendelian diseases. D represents the allele that could not be amplified by locus-specific PCR from single-cell
MALBAC product. Although some SNP loci are not covered by low-depth sequencing in polar bodies, the genotype of FPN can still be accurately
predicted by the haplotype information. See also Figure S5 and Table S5.amplification bias. Luckily, the predetermined haplotype infor-
mation of the cell, which is less sensitive to coverage depth
bias, can be used to determine the chromosome copy number
for five of the six cells successfully.
Besides chromosomal-level aneuploidy, the detection of
missing (or duplication of) smaller DNA segments is also impor-
tant, so we tried to figure out the resolution limit of this method.
We observed that the normalized coverage depth curve is quite
uniform (SD < 0.15) at larger than megabase resolution but gets
very noisy (SD > 2.5) at resolution down to 10 kb (Figures 5C and
S6C). Then we estimated the sensitivity and specificity of aneu-
ploidy detection under different resolutions using the resolved
ploidy information of our oocytes as a reference. We found that
both sensitivity and specificity get higher for lower resolutions,
and it achieves 97.8% sensitivity and 99.5% specificity at
5 Mb resolution (Figure 5C). In fact, for submegabase resolution
(0.5 Mb), it achieves 94.8% sensitivity and 97.5% specificity,
which is superior to most available CGH and SNP array technol-
ogies (Coe et al., 2007).
Aneuploidy in Oocytes
A primary oocyte replicates its diploid genome at prophase I,
forming four copies of chromatids (4C) that are segregated in
sequential two meiotic divisions to generate PB1, PB2, and
FPN. To assess the possibility that aneuploidy arose from the
DNA replication, we checked the sum of the chromatids in
PB1, PB2, and FPN from each oocyte and found that themajority
(43 out of 44) of the primary oocytes implement DNA replication
with high fidelity. Surprisingly, the oocyte S0608 showed a
loss of four chromatids in FPN and a loss of one chromatid in
PB2, whereas no gain of chromatids was detected in PB1
(Figure S6D), which may be caused by the failure of DNA replica-
tion or more likely the wrong segregation of chromosomes
during cell division, such as aberrant segregation of a chromo-1500 Cell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc.some from the whole chromosome set due to an abnormal break
of the spindle (Vogt et al., 2008).
Compared to DNA replication, chromosome segregation in
oocytes is more error prone, probably due to loss of cohesions,
DSBs, or other lesions during long time span of female meiosis
(Kurahashi et al., 2012). We detected 12 aneuploid oocytes
from 8 donors due to abnormal chromatid segregation (Table
S6). The aneuploid chromosomes showed clear patterns of
missing or gaining coverage depth, whereas the other chromo-
somes showed normal coverage depth (Figure S6E). The
average aneuploidy rate for all of the donors is 17.6%, which is
reasonable considering the relatively young ages of the donors
(Figure 5D) (Munne´ et al., 2007). In the 12 aneuploid oocytes,
we detected 28 aneuploid chromosomes, among which meiosis
I error rate is much higher than that of meiosis II, and numerical
(whole chromosome) abnormalities are more common than
structural (part of chromosome) abnormalities (Hassold et al.,
2007) (Figure 5E). Chromosomes 16 and 22 are the most com-
mon aneuploid chromosomes, which is consistent with previous
reports (Pellestor et al., 2002).
Lower Crossover Activity in Aneuploid Oocytes
Homologous recombination is pertinent for proper chromosome
segregation in meiosis (Page and Hawley, 2003), and the reduc-
tion in crossover activity of the whole gamete has been reported
in abnormal sperm (Hann et al., 2011; Lu et al., 2012). Our
method is able to detect crossover and aneuploidy simulta-
neously, giving us the chance to study the relationship between
them. We found that 26 of 28 aneuploid chromosomes do have
crossovers on their sister chromatids, confirming the theory that
each pair of homologous chromosomes has at least one cross-
over (Mets and Meyer, 2009). The reduction of crossover activity
has been reported for many trisomies (Hassold et al., 1995), and
our data also show significant reduction of crossover activity for
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Figure 5. High-Resolution and Accurate Detection of Aneuploidies Facilitates the Study of Aneuploidy Characteristics
(A) Coverage depth after normalization is used to infer the copy number of chromosome segments. A terminal segment of the short arm of chromosome 2 is
missing in PB2, whereas PB1 has an additional copy of it.
(B) Fluctuation of normalized coverage depth denoted by SD is low for most of the sequenced single cells, except for six cells (SD > 0.36). S0113A is the cell with
the most severe fluctuation. As an example, chromosome 10 of this cell and its corresponding PB2 and FPN are shown on the top-right corner.
(C) Sensitivity and specificity of aneuploidy detection under various resolutions. The resolved ploidy information of the oocytes was used as a reference. Note that
the six cells with severe coverage fluctuation and four cells with severe contamination are not used for statistical analysis here. If the expected copy number is n,
then the normalized coverage depth values falling in range of n ± 0.5 were taken as a correct prediction. The averaged SD values under various resolutions are
also shown in comparison with values from simulated sequencing data without any coverage bias.
(D) Comparison of aneuploidy rate among the donors.
(E) Attribution of numerical and structural abnormality to specific meiosis stage.
(F) Difference of crossover numbers between aneuploid and euploid oocyte triads and gamete cells illustrated by p values of Student’s t test. To correct the
inefficiency of crossover detection in aneuploid chromosomes, we replaced the crossover numbers in the aneuploid chromosomes by randomly choosing one
from the corresponding euploid oocytes. The processwas repeated 100 times, and the p valueswere averaged. After correction, the significance level goes down
(p value gets higher) for both the oocyte triad and gamete cell levels.
See also Figure S6 and Table S6.aneuploid chromosomes using the same statistics method
(p value 3 3 104) (Figure S6F). However, these may not be all
of the facts. As the crossovers between the two nondisjunction
chromatids that went into the same aneuploid gamete are hard
to detect from current data, the crossover rate for aneuploidCchromosomes is likely to be underestimated, which contributes
partially to the observed reduction in crossover activity.
We compared the crossover numbers from the aneuploidy
and euploidy groups on both the single-haploid-cell level and
oocyte triad level and observed significantly lower crossoverell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc. 1501
AB
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Figure 6. Deduction of Aneuploidy in IVF
(A) Copy number of chromosomes of FPN can be deduced by its two polar bodies. On the basis of constant total copy number of each genome locus of oocyte
cells (PB1, PB2, FPN), we predict the copy number (black lines) and normalized coverage depth (red or blue dots) for the FPN in 3Mbwindows along the genome
by subtracting the corresponding values of PB1 and PB2 from 4. As an example, the FPN of oocyte S0120 is predicted to have an additional chromosome 19 but
miss chromosome 16 and 22, which was further confirmed by the FPN sequencing.
(B) Influence of sequencing depth on aneuploidy deduction. Three levels of sequencing depth (0.13, 0.013, and 0.0013) were analyzed, and the results suggest
that 0.013 data are sufficient for aneuploidy deduction at megabase resolutions.
(legend continued on next page)
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activity for the aneuploidy group (t test, p = 0.006, on cell level;
p = 0.04, on oocyte triad level) (Figure 5F). The smaller difference
for the oocyte level (higher p value) may be caused by the larger
average number of crossovers and thus less sensitivity to
variations.
To account for the crossover detection defects in aneuploid
chromosomes, we replaced the crossover count on aneuploid
chromosomes by randomly choosing a counterpart from the
euploid group. The p values on both the single-haploid cell
and oocyte level became higher (0.043 and 0.119, averaged by
100 times bootstrapping). An alternative way to make up the
detection defects is to exclude the crossover count of aneuploid
chromosomes from both the aneuploidy and euploidy groups for
statistical analysis (Figure S6G). The results of both analyses
supported that the crossover activity for the aneuploid oocyte
is a little lower than that of the euploid oocyte, but not so much
as the previous studies reported (Bugge et al., 1998; Hassold
et al., 1991).
Deducing Aneuploidy of an Oocyte Based on Polar Body
Sequencing in PGS
As discussed above, aneuploidy of the FPN can be deduced
with the ploidy of the first and second polar bodies without
destroying the fertilized egg. Figure 6A shows the normalized
read density across the 23 chromosomes of the PB1 of the
oocyte S0120, in which aneuploidy is clearly seen at chromo-
somes 2, 16, 19, and 22. It also shows the data for the cor-
responding PB2 of the same oocyte, which has a partial
aneuploidy at chromosome 2. We then predicted what is in the
FPN by subtracting the PB1 and PB2 from 4, which is the ex-
pected total number of chromatids.
To verify the prediction, we directly sequenced the female
pronucleus in the same oocyte under the consent of the donor.
Indeed, the prediction is experimentally verified. As a final check,
we added up the data from PB1, PB2, and the female pronu-
cleus; the number 4 is conserved along the entire genome (Fig-
ure 6A). This result demonstrated the proof of principle of the
IVF procedure for selecting a viable fertilized egg for transfer.
To estimate the minimum sequencing depth needed to
accurately detect aneuploidy in an oocyte cell, we carried out
data analyses by taking a subset of the data from the three
cells of oocyte S0120. The results of predicted copy number
for the FPN with data amount of 3 M (million bases) (0.0013),
30 M (0.013), and 300 M (0.13) are shown in Figure 6B, and
the results of PB1, PB2, and confirmed FPN are shown in
Figure S7A. It is evident that sequencing data as little as 30 M
(0.013) can confidently detect aneuploidy.
At submegabase resolution (0.5 Mb), there is no significant
decrease in detection sensitivity when reducing the sequencing
depth from 13 to 0.013 (Figures S7B and S7C). As aneuploidy(C) Comparison of aneuploidy deduction between MALBAC sequencing and arr
aneuploid eight-cell-stage embryo were analyzed by these two independent m
resolution is 0.5 Mb for MALBAC sequencing, whereas the resolution is 2.5 Mb f
(D) Comparison of aneuploidy deduction between MALBAC sequencing and ar
trophectoderm cells were isolated from an aneuploid blastocyst-stage embryo an
aneuploidy for chromosome 8. The resolution is 0.5 Mb for MALBAC sequencing
See also Figure S7 and Table S7.
Coften spans an entire chromosome, this submegabase reso-
lution is sufficient to determine aneuploidy. The fact that a
sequencing depth of only 0.013 is needed is highly desirable
in order to decrease the cost of PGS in IVF (Table S7).
Comparison with Array CGH
We compared our MALBAC sequencing method with the array
CGH method in accuracy for detecting aneuploidies. An eight-
cell-stage embryo was donated by a couple who already had
one healthy baby from the same oocyte retrieval cycle and
donated their remaining frozen embryos for scientific research
and signed informed consent. We isolated two individual cells
from the eight-cell-stage embryo and analyzed one cell with
MALBAC whole-genome sequencing analysis while examining
the other cell with array CGH analysis with MDA amplification.
As shown in Figure 6C, at whole-genome scale, both methods
can accurately detect aneuploidies. Furthermore, with as low
as 0.13 sequencing depth, MALBAC sequencing results show
digitized signals with much less fluctuation and higher resolution
(0.5 Mb) than the array CGH result (about 2.5 Mb).
Sequencing Blastocysts with MALBAC
When disease-associated SNVs or aneuploidy might come from
the father, PGD/PGS have been carried out with array CGH for
blastocyst biopsy (Broman et al., 1998). A blastocyst-stage
embryo was donated by a couple with the male partner known
to be a carrier of a specific genetic disease. After detection of
the mutation and aneuploidy of these blastocysts by MALBAC
sequencing, one of the aneuploid embryos was also analyzed
by array CGH under the consent of the patient. That is, two
small clumps of a few trophectoderm cells were isolated from
the blastocyst-stage embryo and were analyzed by MALBAC
and array CGH methods side by side, as shown in Fig-
ure 6D. Clearly, the MALBAC result is less noisy and of higher
resolution.
DISCUSSION
We have successfully applied whole-genome amplification
based on MALBAC to single human oocytes, extending the
analyses of single human sperm cells (Lu et al., 2012; Wang
et al., 2012). The genome coverage for a single oocyte cell
when sequenced at 13 is 32%, which is higher than that
reported for a single sperm cell (20%) with comparable
sequencing depth (Lu et al., 2012) probably because of the
looser chromatin structure of oocytes. Distinctly different from
sperm, the oocytes exhibit several features in meiosis, such
as higher recombination rates and higher aneuploidy rates,
yielding the first comprehensive analyses of female meiosis
recombination.ay CGH method for an eight-cell-stage embryo. Two individual cells from an
ethods. Chromosome 14 shows loss of a large segment of its long arm. The
or array CGH.
ray CGH method for a blastocyst stage embryo. Two small clumps of a few
d analyzed by these two independent methods. There is a whole-chromosome
, whereas the resolution is about 2.5 Mb for array CGH.
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This study not only provides information about meiosis of
human oocytes but also yields a procedure for PGS in IVF.
Although more blastocyst biopsies have currently been used in
PGD/PGS, the polar body biopsy has advantages when aneu-
ploidies and disease alleles are inherited from the mother. First,
the polar body biopsy is performed on the oocyte retrieval day
(day 0) rather than day 5, somore time is available for sequencing
and analyses, especially if freezing of embryos needs to be
avoided. Second, blastocyst biopsy removes cells from the
growing embryo, whereas the polar body biopsy removes
genetic material that is dispensable for embryonic development.
However the disadvantages for polar body biopsy are that it
cannot detect the aneuploidies and mutations inherited from
the father and cannot detect the aneuploidies and de novo
mutations arising from mitosis.
By sequencing the first and second polar bodies, we have
provided proof of principle for a low-cost PGS procedure of
selecting fertilized eggs for transfer that are free of maternal
aneuploidy and alleles associated with Mendelian diseases.
The same method in principle can be applied to blastocysts,
considering that the severe genetic variation is either from the
father or the mother. Our MALBAC sequencing offers improved
resolution and accuracy of simultaneous detection of chromo-
some abnormality and heterozygous SNVs associatedwithMen-
delian diseases. The aneuploidy detection by next-generation
sequencing is comparable or even less expensive than CGH
arrays, whereas the disease SNV calling is still costly. As the
sequencing costs decrease rapidly, by offering more accurate
information, our single-cell amplification method will gain more
advantages in the future. Such a single-cell manipulation and
diagnosis allows probing and bettering of life at the single-mole-
cule level.
EXPERIMENTAL PROCEDURES
Donor Recruitment and Oocyte Retrieval
This study has been approved by the Reproductive Study Ethics Committee at
Peking University Third Hospital (research license 2012SZ014). All oocytes
and spermwere obtained with informed consent, which confirmed that donors
voluntarily donated oocytes and sperm. All of the procedures for oocyte
collection and operation were performed following standard clinical protocols
(Li et al., 2008). The oocyte donors have already had one or two healthy
children from natural pregnancy, and they donated their oocytes purely for
research purposes.
Isolation and MALBAC Whole-Genome Amplification of Single Polar
Bodies and Pronuclei
The first polar bodies (PB1) and second polar bodies (PB2) were sequentially
picked after ICSI. The male and female pronuclei were removed after the
zygote entered pronuclear stage. Each single-cell sample was assigned a
unique cell ID beginning with an ‘‘S,’’ followed by a four-digit number and an
alphabetic letter. Suffixes of single-cell ID ‘‘A, B, and C’’ mean PB1, PB2,
and FPN, respectively. Each polar body or pronucleus was transferred
into individual PCR tubes and lysed in 5 ml lysis buffer. The DNA released
from the lysed cell in each tube was amplified using MALBAC (Zong et al.,
2012).
High-Throughput Sequencing and Prefiltering of the Sequencing
Data
The qualified amplified genomic DNA was used to construct Illumina libraries
for high-throughput sequencing. The MALBAC amplification primers, Illumina1504 Cell 155, 1492–1506, December 19, 2013 ª2013 Elsevier Inc.library adapters, and unreliable low-quality read ends were trimmed from the
raw sequencing data.
Calling of Heterozygous SNPs for the Donor and Genotype
Determination of the Oocyte Cells
The confident heterozygous SNPs for each donor were determined by inte-
grating all the genotype likelihoods of all her oocyte cells. With the donor’s
heterozygous SNP information, the posterior probabilities for each SNP allele
were estimated in each oocyte cell by the Bayesian theory.
Phasing Heterozygous SNPs and Inferring Genome Positions of
Crossovers
The hetSNPs of the donor were phased, and the genome positions of cross-
overs were inferred in all oocyte cells by two independent algorithms, and
these two algorithms generated largely consistent results. Additional details
are provided in the Extended Experimental Procedures.
Normalization of Coverage Depth and Aneuploidy Detection
For each cell, the normalized coverage depth was calculated by dividing
the averaged raw depth of several cells from the same window, as well
as the sequencing depth of the given sample. Aneuploidy was identified
when the observed copy number was different from the expected ones.
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